Conshohocken, Pennsylvania-based Cencora, Inc. (COR) sources and distributes pharmaceutical products. Valued at $58.7 billion by market cap, the company offers end-to-end pharmaceutical commercialization solutions, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers. Companies worth $10 billion or more are generally described as “large-cap stocks.” COR effortlessly fits that bill, with its market cap exceeding this mark, underscoring i ...